Veterinary Ache Administration Market Value USD 4.58 Billion By 2027 at 6.46% CAGR

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

The main players in the veterinary pain management market are Boehringer Ingelheim (Germany), Norbrook Laboratories (UK), Ceva (USA), Eltech K-Laser (Italy), Zoetis (USA), Elanco (USA) and Assisi Animal Health (USA). , Bayer AG (Germany), Chanelle Pharma Group (Ireland), Merck Animal Health (USA), Vetoquinol SA (France) and Dechra Pharmaceuticals PLC (Great Britain).

Pune, India, February 11, 2021 (GLOBE NEWSWIRE) – Veterinary Pain Management Market Overview

Market Research Future (MRFR) examined the global veterinary pain therapy market 2020 in the analysis period to 2027. By 2027, the global veterinary pain therapy market is expected to increase at high CAGR and reach a market size of approximately USD 4,582.8 million.

The easy availability and affordability of pain management devices and products such as Opioid, nonsteroidal anti-inflammatory drugs (NSAIDs), local anesthetics, laser devices, and αlpha 2 adrenergic agonists, which are used to relieve pain in diseases such as: Musculoskeletal disorders, osteoarthritis, radiation therapy-induced pain, chemotherapy, and mastitis among others; can earn substantial revenue for the market.

The increase in pet ownership in developing and industrial regions can also benefit the market. In addition, the presence of a large animal population and the increase in pet insurance are other causes that may contribute to the increase in the regional market during the analysis period.

Contribution of the main actors to a significant influence on the competitive landscape

Some of the top companies featured in the MRFR report are:

  • Boehringer Ingelheim (Germany)

  • Norbrook Laboratories (UK)

  • Something (US)

  • Eltech K-Laser (Italy)

  • Zoetis (USA)

  • Elanco (USA)

  • Assisi Animal Health (USA)

  • Bayer AG (Germany)

  • Chanelle Pharma Group (Ireland)

  • Merck Animal Health (USA)

  • Vetoquinol SA (France)

  • Dechra Pharmaceuticals PLC (UK)

The expansion of the veterinary pain management market is largely influenced by the contribution of the major players. MYOS CORP, an emerging company engaged in the manufacture of advanced nutritional products to increase muscle strength, announced the formation of a Veterinary Advisory Board. Seven renowned executives from science and private practice will support MYOS CORP in the expansion of the company’s animal health industry. Robust corporate initiatives can have a positive impact on the market. INDIBA®, a leading provider of radio frequency technology, launched OKTO, a device that helps treat pain through neuromodulation and metabolic stimulation of biological tissues. This shows that innovations and upgrades to existing models can support the rise of the veterinary pain management market in the review period. The report discusses other key contributions from these committed players that may impact market growth dynamics amid the COVID 19 pandemic. Insights into the competitive landscape of the market can help stakeholders make better investment decisions.

The story goes on

Get a Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/5961

Segment analysis

The segment analysis of the global veterinary pain therapy market is done by application, product, sales channel and animal type.

By Product Type, the global Veterinary Pain Management Market is segmented into Devices and Drugs. The drug segment includes opioids, non-steroidal anti-inflammatory drugs (NSAIDs), local anesthetics, muscle relaxants, A2 adrenergic agonists and sedatives. The NSAIDs segment examines meloxicam and etodolac, among others. The opioid subsegments analyze fentanyl, morphine, codeine and hydromorphone, among others. The study on the local anesthetic segment is based on, among other things, bupivacaine, lidocaine and chloroprocaine. The market study based on A2 adrenergic agonists is carried out for xylazine and medetomidine. The veterinary pain reliever market is being studied for oral, topical and parenteral parameters for the route of administration. The device-based assessment of the veterinary pain therapy market is carried out for electromagnetic therapy devices and laser therapy devices.

The animal market for veterinary pain therapy is divided into farm animals and domestic animals according to animal species. The market study for the companion animal segment is carried out on cats, horses and dogs, among others. The segment analysis of the market on the basis of farm animals is carried out on poultry, cattle and pigs, among others.

The application divides the global veterinary pain management market into post-operative pain, joint pain, and cancer, among others. The joint pain segment is analyzed on the basis of musculoskeletal disorders and osteoarthritis.

The channel-based segments of the global veterinary pain therapy market are pharmacies, online pharmacies, and veterinary clinics and clinics.

Search the detailed market research report (245 pages) below Veterinary pain therapy: https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

Regional study:

North America achieves high returns for the global market

In America, North America after Latin America are thoroughly examined for market analysis. The Veterinary Pain Management market can see a reasonable CAGR through 2027. The expansion of the pet population and the increase in animal populations, which require high numbers of veterinarians in the area, can support the market expansion. The rise in support from regulatory agencies such as: The American Veterinary Medical Association (AVMA) may help expand the market in the near future to make veterinary practices easier to operate.

In Europe, market veterinary pain therapy is being examined for Italy, France, Great Britain, Spain and Germany. According to the MRFR study, Europe can generate significant gains for the world market, with the UK securing the largest market share for the region. The growth of the veterinary pain management market can be attributed to the presence of a large population of domestic animals.

Share your questions @ https://www.marketresearchfuture.com/enquiry/5961

In the Asia-Pacific region, it is exploring the expansion of the veterinary pain management market to Japan, China, South Korea, Australia and India. In the Asia-Pacific region, the market can grow with the highest CAGR between 2020 and 2027 during the reporting period. The expansion of the veterinary sector and the increase in the number of private veterinary clinics may support the expansion of the market in the near future. Increased awareness of government campaigns and animal welfare for pets across South Korea and Australia can help boost the regional market.

The Middle East and Africa veterinary pain management market is expected to make substantial gains. The surge in the veterinary pain management market in MEA is due to the presence of veterinarians and the growing concern of animal adoption agencies and people about the welfare of these actors.

Explore more research reports on the medical device industry by market research future:

Market size, share and growth analysis for cosmetic surgery; by type of operation (liposuction, eyelid and nose surgery, body contouring (tummy tuck, breast lift, others), facial reconstruction, cosmetic implants (breast augmentation, buttock implants, chin and cheek implants, and others) – prognosis until 2023

Sports medicine market intelligence; By product (joint reconstruction and repair products, support and restoration products, accessories and consumables, others), by application (shoulder treatment, knee treatment, hip treatment, spine treatment, other), by procedure (tendinitis, bone tendon, cartilage repair)) and by end users (hospitals and Emergency Care, Trauma Centers, Outpatient Care, Others) – Global Forecast to 2023

Wound Care Market Research Report by Product (Wound Therapy Devices, Traditional and Active Wound Care Products), Type (Chronic, Acute), Application (Ulcers, Burns, Trauma Wounds), End-Users (Hospitals, Clinics, Trauma Center) – Global Forecast to 2027

Smart Contact Lenses market information, by application (continuous glucose monitoring, intraocular pressure monitoring), by end-user type (hospitals, clinics, and home care settings) – forecast to 2023

About the future of market research:

Market Research Future (MRFR) is a global market research firm that prides itself on its services, providing complete and accurate analysis in relation to various markets and consumers worldwide. Market Research Future has the outstanding goal of offering customers optimal research quality and granular research. Our market research studies of products, services, technologies, applications, end users, and market participants for global, regional, and country specific market segments enable our customers to see more, know more, and do more to answer your key questions.

Follow us: LinkedIn | Twitter

CONTACT: Contact: Market Research Future Phone: +1 628 258 0071 (USA) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com